Clinical Trial Update: QTc Assessment in a Single-Dose Study of Hydronidone Capsules [Phase 1]

View source ↗

Summary

Hydronidone capsules were evaluated in a Phase 1 single-dose QTc assessment study. The hepatic fibrosis trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Fibrosis

Drugs mentioned

• Hydronidone Capsules

Snippet

Sponsor: Beijing Continent Pharmaceutical Co, Ltd. | Conditions: Hepatic Fibrosis | Phase 1 | Status: COMPLETED